Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The paracrine cytokine and growth factor network is a fundamental system of local intercellular communication where cells secrete signaling molecules to influence the behavior of adjacent cells (Alberts et al., Molecular Biology of the Cell). This network comprises a vast array of proteins, including interleukins, chemokines, and growth factors such as Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor-beta (TGF-beta), which are essential for maintaining tissue homeostasis and coordinating immune responses (Nature Reviews Molecular Cell Biology). In pathological conditions, such as cancer and chronic inflammation, these networks become dysregulated, often creating a microenvironment that supports tumor growth, angiogenesis, and immune evasion (Hanahan & Weinberg, Cell). Therapeutic strategies frequently target specific nodes within this network, utilizing monoclonal antibodies to neutralize ligands or small molecules to inhibit receptor tyrosine kinases (Journal of Clinical Investigation). However, the pleiotropic nature of these signaling molecules means that inhibiting one pathway can lead to significant side effects or the activation of compensatory mechanisms (StatPearls, Cytokines). Consequently, while the network as a whole is a critical driver of disease, drug development focuses on precisely modulating individual components to achieve therapeutic efficacy while minimizing toxicity.
Inhibition of specific signaling nodes within the network, including ligand neutralization, receptor antagonism, or kinase inhibition.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine cytokine and growth factor network.